首页> 外国专利> COMPOSITION FOR DIAGNOSING HEPATOCYTES COMPRISING A MATERIAL MEASURING SPECIFIC GENE IN LIVER CANCER TISSUE AT MRNA LEVEL AND A MATERIAL MEASURING THE PROTEIN ENCODING THE GENE

COMPOSITION FOR DIAGNOSING HEPATOCYTES COMPRISING A MATERIAL MEASURING SPECIFIC GENE IN LIVER CANCER TISSUE AT MRNA LEVEL AND A MATERIAL MEASURING THE PROTEIN ENCODING THE GENE

机译:用于诊断肝细胞的组合物,该组合物包括在MRNA水平上测定肝癌组织中特定基因的材料和编码该基因的蛋白的材料

摘要

PURPOSE: A composition and kit for diagnosing cancer is provided to early discover HCC(hepatocellula cartinoma) and screen novel anti-cancer drugs.;CONSTITUTION: A composition for diagnosing liver cancer comprises a material measuring genes such as ZFP36(zinc finger protein 36), PDLIM1(PDZ and LIM domain 1) or CA2(carbonic anhydrase II) at mRNA level and a material measuring protein encoding the gene. A method for screening an anticancer drug comprise: a step of culturing a cell in which the ZFP36, PDLIM1 or CA2 gene in cells; a step of treating a candidate which increases or decreases the expression of the protein encoding the ZFP36, PDLIM1 or CA2; and a step of comparing the expression level with control group.;COPYRIGHT KIPO 2010
机译:目的:提供一种用于诊断癌症的组合物和试剂盒,以及早发现HCC(肝细胞癌)并筛选新型抗癌药物。;构成:一种用于诊断肝癌的组合物包含一种可测量基因的物质,例如ZFP36(锌指蛋白36) ,mRNA水平的PDLIM1(PDZ和LIM结构域1)或CA2(碳酸酐酶II)以及测量编码该基因的蛋白质的材料。一种筛选抗癌药物的方法,包括:培养细胞中含有ZFP36,PDLIM1或CA2基因的细胞的步骤;治疗候选物的步骤,所述候选物增加或减少编码ZFP36,PDLIM1或CA2的蛋白质的表达;以及将表达水平与对照组进行比较的步骤。; COPYRIGHT KIPO 2010

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号